1-10 of 10
desire for food
Close
Sort by
Journal Articles

Geriatric Assessment (GA) Measures and Patient-Reported Outcomes (PROs) Among Older Adults Treated in a Phase 1b Study for Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Heidi D. Klepin, MD MS, Avrita Campinha-Bacote, Wan-Jen Hong, Patrick Phuong, Jue Wang, Mehrdad Mobasher, MD MPH, Peter Trask
Journal: Blood
Blood (2018) 132 (Supplement 1): 4076.
https://doi.org/10.1182/blood-2018-99-116038
Published: 2018
Journal Articles

A Phase 1 Dose Escalation Study of ARQ 531 in Selected Patients with Relapsed or Refractory Hematologic Malignancies

Jennifer A. Woyach, MD, Ian W. Flinn, MD PhD, Deborah M. Stephens, Farrukh T. Awan, MD MS, Kerry A. Rogers, MD, Sean D. Reiff, Ron E. Savage, Sudharshan Eathiraj, Lyndsey A. Szuszkiewicz, Kate Tith, John C. Byrd, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3136.
https://doi.org/10.1182/blood-2018-99-116338
Published: 2018
Journal Articles

Correlation between MPN-SAF TSS and EORTC QLQ-C30 Scores in Patients with PV: Data from the Reveal Study

Ivy Altomare, MD, Aaron T. Gerds, MDMS, David Lessen, MD, Philomena Colucci, DO, MS, Shreekant Parasuraman, BPharm, PhD, Dilan Chamikara Paranagama, PhD, Ruben A. Mesa, MD FACP
Journal: Blood
Blood (2018) 132 (Supplement 1): 2259.
https://doi.org/10.1182/blood-2018-99-112937
Published: 2018
Journal Articles

The mouse that lost its appetite for human

William G. Kerr
Journal: Blood
Blood (2013) 122 (25): 4003–4004.
https://doi.org/10.1182/blood-2013-09-527614
Published: 2013
Journal Articles

Results of the OPAL Study: A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of Tosedostat (CHR-2797) in Elderly Subjects with Treatment Refractory or Relapsed Acute Myeloid Leukemia

Jorge E. Cortes, Eric J Feldman, MD, Karen Yee, MD, David A. Rizzieri, MD, Anjali S. Advani, MD, Anthony Charman, PhD, Martin J. Toal, FFPM, Hagop M. Kantarjian
Journal: Blood
Blood (2011) 118 (21): 767.
https://doi.org/10.1182/blood.V118.21.767.767
Published: 2011
Journal Articles

Targeting EVI1-Overexpressing AML with Darinaparsin

Koren K Mann, PhD, Nathalie Johnson, MD, Torsten Holm Nielsen, MD, Nicolas Garnier, MSc, Stanley Kwan, Eftihia Cocolakis, PhD, Josee Hebert, MD, Robert Morgan, MSc, Wilson H. Miller, Jr., MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4269.
https://doi.org/10.1182/blood.V118.21.4269.4269
Published: 2011
Journal Articles

Health Related Quality of Life (HRQOL) in Patients Receiving Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) or Fludarabine and Cyclophosphamide (FC) for First Line Therapy with Advanced Chronic Lymphocytic Leukemia (CLL).

Barbara F. Eichhorst, MD, Kirsten Fischer, Anna- Maria Fink, MD, Guenter Fingerle-Rowson, MD, PhD, Anne Westermann, Clemens-Martin Wendtner, MD, Raymonde Busch, Michael Hallek, MD
Journal: Blood
Blood (2009) 114 (22): 3438.
https://doi.org/10.1182/blood.V114.22.3438.3438
Published: 2009
Journal Articles

Pharmacokinetic Results from a Phase 1 Study of a Multi-Targeted Tyrosine Kinase Inhibitor, ABT-869, in Patients with Refractory or Relapsed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Wendy Stock, MD, Karen WL Yee, MD, Eunice S. Wang, MD, Sari Enschede, MD, Joyce Steinberg, MD, Rod Humerickhouse, MD, PhD, Qin Qin, PhD, Jiang Qian, PhD, Yi-Lin Chiu, PhD, Neeraj Gupta, PhD, Rajendra Pradhan, PhD
Journal: Blood
Blood (2008) 112 (11): 4008.
https://doi.org/10.1182/blood.V112.11.4008.4008
Published: 2008
Journal Articles

Baseline Characteristics Associated with Quality of Life in CLL Patients Requiring Therapy.

Monica Else, MSc, Alastair G. Smith, MD, Sue M. Richards, DPhil, Kim Cocks, MSc, Shirley Crofts, MSc, Daniel Catovsky, MD
Journal: Blood
Blood (2007) 110 (11): 2062.
https://doi.org/10.1182/blood.V110.11.2062.2062
Published: 2007
Journal Articles

Dectin-1: unique appetite for yeast

Cees van Kooten
Journal: Blood
Blood (2004) 104 (13): 3846.
https://doi.org/10.1182/blood-2004-09-3641
Published: 2004